Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy)
BEHAVIORAL
2 trials
Sponsors
NYU Langone Health
, University of California, Los Angeles
Conditions
Smoking
Smoking Cessation
Smoking, Tobacco
Tobacco Use Cessation
Tobacco Use Disorder
Unknown Phase
Financial Incentives for Smoking Treatment
Completed
NCT02506829
NYU Langone Health
Smoking, Smoking, Tobacco, Tobacco Use Disorder
Start: 2015-07-31
End: 2019-05-20
Updated: 2020-12-11
Financial Incentives for Smoking Treatment II
Active, not recruiting
NCT03979885
University of California, Los Angeles
Smoking Cessation, Tobacco Use Cessation
Start: 2020-01-06
End: 2027-06-30
Target: 1058
Updated: 2026-04-29
Related Papers
Goal-directed versus outcome-based financial incentives for smoking cessation among low-income, hospitalised patients: rationale and design of the Financial Incentives for Smoking Treatment II (FIESTA II) randomised controlled trial
BMJ Open
2023-09-01
1 citations
Goal-directed versus outcome-based financial incentives for weight loss among low-income patients with obesity: rationale and design of the Financial Incentives foR Weight Reduction (FIReWoRk) randomised controlled trial
BMJ Open
2019-04-01
13 citations
Financial IncEntives for Smoking TreAtment: protocol of the FIESTA trial and FIESTA Oral Microbiome Substudy.
2018-11-21
4 citations